Serial cardiovascular magnetic resonance evaluation of children and young adults with sickle cell disease (SCD) who underwent hematopoietic cell transplantation (HCT) showed that the mean ECV, representing diffuse myocardial fibrosis, decreased by 3.4% from the baseline to 12-months post HCT. (NCT04362293)

Subjects:
Transplantation
This content is only available as a PDF.
Copyright © 2024 American Society of Hematology
2024

Article PDF first page preview

Article PDF first page preview
You do not currently have access to this content.
Sign in via your Institution